Celeste R Caulder1, Brenna Mehta2, P Brandon Bookstaver3, LaVetra D Sims4, Bill Stevenson5. 1. Assistant Professor, Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy, University of South Carolina , Columbia, South Carolina. 2. Drug Information, Palmetto Health Richland , Columbia, South Carolina. 3. Associate Professor and Vice Chair, Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy, University of South Carolina , Columbia, South Carolina. 4. PGY-1 Pharmacy Resident, Carolinas Medical Center , Charlotte, North Carolina. 5. Director of Pharmacy Services, Oconee Medical Center, Seneca , South Carolina.
Abstract
BACKGROUND: Drug shortages have become all too common and affect all aspects of the health care delivery system. The increased number of drug shortages has had a negative impact on patient care as well as costly financial implications. OBJECTIVES: This article identifies the current problems and negative outcomes drug shortages have caused and provides a framework for how to best prepare for and combat future shortages. It highlights specific problems faced by health care system pharmacies in the Southeastern United States and the managerial responses to address these shortage situations. METHODS: A 34-question, multiple-choice survey was distributed to pharmacy directors in North Carolina, South Carolina, Georgia, and Florida. RESULTS: Of 549 surveys distributed, 219 (40%) responses were received. Respondents reported that drug shortages cause 1% to 5% error rates in hospitals and that 60% of the time drug shortages create unsafe conditions for patients and staff. Many of the respondents reported a 300% to 500% markup on medications on the shortage list. Seventy-six percent of institutions have autosubstitutions for drug shortages that have been preapproved by Pharmacy & Therapeutics Committees. CONCLUSIONS: The causes of drug shortages are multifaceted, and the safety and financial implications can be costly. In the short term, health care institutions can utilize pharmacists to assist in circumventing the drug shortage problem. The combined efforts of all health care professionals, the US government, manufacturers, and the lay public are necessary to bring awareness and plausible solutions to the drug shortage problems in the long term.
BACKGROUND: Drug shortages have become all too common and affect all aspects of the health care delivery system. The increased number of drug shortages has had a negative impact on patient care as well as costly financial implications. OBJECTIVES: This article identifies the current problems and negative outcomes drug shortages have caused and provides a framework for how to best prepare for and combat future shortages. It highlights specific problems faced by health care system pharmacies in the Southeastern United States and the managerial responses to address these shortage situations. METHODS: A 34-question, multiple-choice survey was distributed to pharmacy directors in North Carolina, South Carolina, Georgia, and Florida. RESULTS: Of 549 surveys distributed, 219 (40%) responses were received. Respondents reported that drug shortages cause 1% to 5% error rates in hospitals and that 60% of the time drug shortages create unsafe conditions for patients and staff. Many of the respondents reported a 300% to 500% markup on medications on the shortage list. Seventy-six percent of institutions have autosubstitutions for drug shortages that have been preapproved by Pharmacy & Therapeutics Committees. CONCLUSIONS: The causes of drug shortages are multifaceted, and the safety and financial implications can be costly. In the short term, health care institutions can utilize pharmacists to assist in circumventing the drug shortage problem. The combined efforts of all health care professionals, the US government, manufacturers, and the lay public are necessary to bring awareness and plausible solutions to the drug shortage problems in the long term.
Entities:
Keywords:
drug shortage; medication error; price gauging
Authors: Amanda M Baumer; Angela M Clark; David R Witmer; Shirley B Geize; Lee C Vermeulen; Joseph H Deffenbaugh Journal: Am J Health Syst Pharm Date: 2004-10-01 Impact factor: 2.637
Authors: Marisa N Mendez; Laurel Gibbs; Richard A Jacobs; Charles E McCulloch; Lisa Winston; B Joseph Guglielmo Journal: Pharmacotherapy Date: 2006-01 Impact factor: 4.705
Authors: Sarah L Clark; Kimberly Levasseur-Franklin; Mehrnaz Pajoumand; Megan Barra; Michael Armahizer; Deepa V Patel; Katleen Wyatt Chester; Andrea P Tully Journal: Neurocrit Care Date: 2020-02 Impact factor: 3.210